Similarly, effects on glucose metabolism, insulin resistance, pancreatic β cell function and risk of diabetes are attributed to elevations in TNFα and IL-1β [6, 15, 18, 19], whilst IL-1β antagonism reduces hyperglycaemia and improves pancreatic β cell function in patients with T2D [20, 21]. Here, IL1B is linked to diabetes mellitus.